Exor Capital LLP Moderna, Inc. Transaction History

Exor Capital LLP

$3.23 Billion
Q3 2024

A detailed history of Exor Capital LLP transactions in Moderna, Inc. stock. As of the latest transaction made, Exor Capital LLP holds 373,095 shares of MRNA stock, worth $15.3 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

373,095

Previous 348,095 7.18%

Holding current value

$15.3 Million

Previous $41.3 Million 39.68%

% of portfolio

0.77%

Previous 1.49%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $1.59 Million - $3.13 Million	25,000 Added 7.18%	373,095 $24.9 Million
Q2 2024 Aug 12, 2024	BUY	$101.21 - $166.61 $4.55 Million - $7.5 Million	45,000 Added 14.85%	348,095 $41.3 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $5.98 Million - $8.08 Million	70,000 Added 30.03%	303,095 $32.3 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $6.95 Million - $10.4 Million	100,000 Added 75.13%	233,095 $23.2 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $15.8 Million - $21.4 Million	133,095 New	133,095 $16.2 Million

Others Institutions Holding MRNA

# of Institutions

952

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exor Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Exor Capital LLP with notifications on news.

Account